1. The influence on leucine disposal of physiological alterations in plasma insulin concentrations was examined in three groups of healthy male subjects, six in each group. After an overnight fast the subjects received an intravenous infusion of either leucine (300 p o l l m i n for 150 min, series A), or leucine plus glucose (2.2 mmol/min, series B), or leucine, somatostatin (7 pg/min) and glucagon (1 ng/min, series C). Arterial concentrations of substrates and their net exchange across the splanchnic and leg tissues were determined with a catheter technique.
Introduction
The three branched chain amino acids leucine, isoleucine and valine have recently attracted much interest (for a recent review see [l] ). Of the three, leucine seems to be of special importance. Thus it has been suggested that leucine, but not valine or isoleucine, influences the regulation of protein synthesis and catabolism in skeletal muscle [2, 3] . Moreover, leucine is known to be a potent stimulator of insulin secretion [4] and an inhibitor of urea synthesis in the liver [5] .
The plasma concentration of leucine, as well as of the other two branched chain amino acids, varies considerably in response to hormonal and nutritional alterations in man. Thus, in diabetes [6] , obesity [7] and starvation [8] the levels of the branched chain amino acids are elevated, and chronic liver disease [9] and protein malnutrition [lo] are accompanied by low concentrations of these amino acids. The factors regulating these plasma concentrations are not well understood but it has been suggested that altered insulin levels are important [6] [7] [8] 111 . Thus physiological increments of insulin are known to inhibit the release of leucine and other amino acids from skeletal muscle in [15] . Whether this also applies in intact man is not known.
An improved understanding of insulin's role in leucine metabolism would be of interest for normal physiology as well as for a variety of clinical disorders. The present study was therefore undertaken to define further the role of insulin in the disposal of leucine in intact man. Leg and splanchnic exchanges of leucine were examined during intravenous leucine infusion in conjunction with varying insulin levels in three groups of healthy volunteers.
Procedure and methods

Subjects
Eighteen healthy non-obese male volunteers, assigned to three groups, were studied. Their average age was 26 * 1 years, weight 76 f 2 kg and height 182 f 2 cm. The purpose and possible risks involved in the study were carefully explained to each subject before obtaining his consent to participate. The experimental protocol was reviewed and approved by the institutional ethics committees.
Bocedure
All studies were performed in the morning after an overnight fast. During local anaesthesia, catheters were inserted percutaneously into an artery, a femoral vein and an antecubital vein. In addition, a catheter (Cournand no. 8) was introduced percutaneously into the femoral vein and guided under fluoroscopic control into a right-sided hepatic vein. The tip of the catheter was placed 3-4 cm from the wedge position.
After a basal period, three experimental series were performed. In series A a continuous intravenous infusion of leucine (300 pmol/min) was given for 150 min. In series B an intravenous infusion of leucine (300pmol/min) and glucose (2.2 mmollmin) was given for 150 min and in series C a combination of leucine (300 pmollmin), somatostatin (7 pg/min) and glucagon (1 nglmin) was infused intravenously for 150 min. Arterial, femoral venous and hepatic venous blood samples were collected at timed intervals before and during the infusions for analysis of amino acids, insulin, glucose and ketone bodies. Leg [16] and hepatic blood flows [ 171 were determined by using indicator dilution techniques based on continuous infusion of indocyanine green dye. Sterile L-leucine solution (2%) was generously supplied by KabiVitrum AB, Sweden.
Methods
Amino acids were analysed in whole blood after precipitation of proteins with 15% sulphosalicylic acid using an automated ionexchange chromatograph (Liquimat 111, Kontron, Switzerland Leg and splanchnic exchanges were calculated as the product of blood flow and regional arteriovenous concentration differences. Standard statistical methods were employed, the paired t-test being used when applicable. Results from series A have in part been published elsewhere [21] .
Results
Insulin
In series A the basal insulin level was 12 * 1 punitslml and there was a rise to 20-22 p-unitslml during leucine infusion (P < 0.05, Fig. 1 ). During infusion of leucine plus glucose in series B, the insulin concentration increased gradually and reached a level of 60-65 p-unitslml after 120-150 min. In series C, involving infusion of leucine, somatostatin and glucagon, insulin fell to levels between 4 and 6 p-unitslml during the infusion.
Glucose
The basal glucose concentration for all subjects was 4.23 f 0.15 mmol/l. In series A blood glucose decreased slightly during the infusion period (to 3.85-3.95 mmol/l,P< 0.05, Fig. 1) . A marked rise in blood glucose was seen in series B; the levels reached a peak of 8.3 +0.4mmol/l at 90min of infusion (P< 0.01) and then declined to 6.4 0.5 mmol/l at the end of the infusion. In series C, glucose rose gradually to 7.9 0.8 mmol/l after 150 min of infusion.
Leucine
In the basal state the arterial leucine concentration for all subjects was 109 f 8 pmolll. In all three series there was a gradual rise during infusion ( Fig. 1) . For the fist 60-90 min the levels were similar in the three groups but at the end of the infusion they differed slightly. Thus leucine concentration after 150 min of infusion was 598 * 20 To further evaluate the interaction between plasma insulin levels and leucine metabolism, we studied the relationship between changes in arterial leucine and arterial insulin concentrations. The data suggest a negative curvilinear relationship; small changes in insulin from the basal level markedly influence the leucine levels during infusion, whereas greater changes, e g . during combined leucine and glucose infusion, are accompanied by proportionately smaller alterations in leucine levels during infusion (Fig. 1) . Net leucine exchange across the leg tissues in the basal state was -3.0 k 1.0 pmol/min (series A-C), indicating a small net release of leucine (P< 0.05). The net balance across the leg changed to an uptake (77 k 18pmol/min) during the infusion in series A (Fig. 2) . The corresponding values for series B and C were 85 k 12 and 8 6 k 14 pmollmin respectively; no differences of statistical significance were observed between the groups.
There was no significant net exchange of leucine across the splanchnic tissues in the basal state (-2.8 2 3.0 pmol/min). During infusion a net splanchnic uptake of leucine was observed in all subjects; in series A this uptake was 61 f 6 pmol/ min, in series B 65 2 6 pmol/min and in series C 72 k 10 pmol/min (Fig. 2) . The differences between the groups did not reach statistical significance. No statistically significant relationships were found between net splanchnic or leg uptake of leucine and the concurrent insulin levels.
Amino acids
The arterial concentrations of 12 amino acids are presented in Table 1 . During leucine infusion Probability that differences from the corresponding values in the basal state are caused by random factors: * P < 0.05; **P < 0.01 ; ***P < 0.001. (series A) there was a 20% increase in taurine and the concentrations of most other amino acids decreased. The fall was most pronounced for valine, isoleucine, methionine, tyrosine and phenylalanine (30-40%, P < 0.01) but significant decreases were also seen for threonine, serine, glycine, alanine and histidine (6-20%, P<O.Ol-0.001). In series B the concentrations of the former amino acids declined more than in series A (30-80%, P < 0.01-0.001), except for methionine, whose concentration was unchanged in series B. In series C, on the other hand, the falls in amino acid concentrations (threonine, valine, methionine, isoleucine, tyrosine and phenylalanine) were generally smaller than in series A (4-40%). For glutamine a small rise in arterial level (+ 15%, P < 0.01) was observed in series C.
Concentration bmol/l) Change
None of the three infusions had a significant effect on the net exchange of amino acids (other than leucine) in the splanchnic area or the leg. However, when leucine alone was infused (series A), there were significant splanchnic uptakes of valine 
Ree fatty acids and ketone bodies
Free fatty acid (FFA) levels were unchanged during leucine infusion ( Table 2 ) . In series B arterial FFA declined to 20% of the basal level, although in series C there was an increase of 80%.
The concentrations of 3-hydroxybutyrate and acetoacetate in the basal state were 129 f 27 and 81 i 10 pmol/l respectively. In series A there was a progressive increase in both ketone bodies to levels approximately 150% above the basal ( Table   2 ) . In series B the combined levels of ketone bodies declined by 70-80%, and in series C there was a prompt, sustained rise to three-to foudfold the basal levels. Splanchnic production of ketone bodies is shown in Table 2 . Total ketone body output rose by 50% during leucine infusion in series A, whereas in series C the rise was approximately 100%. In series B, on the other hand, ketone body production was totally abolished during the infusion period.
Blood flows
Leg blood flow in the basal state was 0.5 f 0.05 l/min (series A-C) and did not change during the infusions. Estimated hepatic blood flow in the basal state was 1450 f 80 ml/min, and decreased slightly but not significantly during the infusions to 1260 f 80 ml/min.
Discussion
The present data demonstrate that the plasma insulin level influences the disposal of intravenously administered leucine in intact man. Thus, hyperinsulinaemia was associated with a lower and hypoinsulinaemia with a higher accumulation of ---blood leucine during intravenous infusion of this amino acid. Furthermore, the data suggest a negative curvilinear relationship between the changes in arterial levels of leucine and insulin.
However, insulin appears to exert only a minor effect on leucine disposal, inasmuch as the changes in arterial leucine were only of the order of 10% (Fig. 1) . The site of this insulin action could not be detected in the present study. Despite the variations in arterial leucine levels, alterations in insulin availability did not measurably influence the net exchange of leucine across the splanchnic or leg tissues. The possibility may be considered that insulin influences the distribution volume rather than the net regional exchange. However, in a recent study in dogs using a combination of catheter and isotope techniques, hyperinsulinaemia was followed by a retarded appearance and an augmented clearance of leucine, as well as a fall in the arterial concentration of this amino acid [22] .
Regional measurements indicated that diminished release of leucine from both liver and hind-limb tissues contributed to the fall in arterial concentration. The discrepant findings in the present study compared with that of Abumrad et ~l .
[22] may be caused by species differences. Alternatively, they may reflect the fact that the magnitude of the insulin effect on leucine disposal in man is too small to be detectable with the errors inherent in the net balance studies.
The elevated leucine levels obtained in the present study may be another complication in the evaluation of the regional exchanges. At basal leucine concentrations, physiological increments of insulin have been demonstrated to inhibit the release of leucine from forearm muscle, while no net uptake was observed during insulin administration [12] . Similarly, in a recent study using the insulin clamp technique, neither the leg nor the splanchnic tissues were found t o take up measurable amounts of leucine in response to hyperinsulinaemia [23] . It would thus appear that neither at basal levels nor at elevated concentrations does insulin result in a measurable increase in net leucine uptake by muscle or splanchnic tissues in man.
The possibility may be considered that the insulin-sensitive step in leucine disposal may reside in an extrahepatic or extramuscular site. In this regard it is well established that insulin may accelerate uptake and oxidation of branched chain amino acids in adipose tissue in vitro [14, 24] .
However, if this were the case in the present study one would in fact expect to see an influence of insulin on leucine uptake by the legs and the splanchnic tissues, since the femoral and hepatic veins drain subcutaneous and omental adipose tissue respectively. Finally, experimental studies have demonstrated that leucine may be metabolized also by the heart [25] , the brain [26] and the kidneys [27] , and the possibility cannot be excluded that insulin may mediate an effect on leucine uptake by these tissues.
Irrespective of the insulin levels, a net leucine uptake by the leg was observed during all three infusions. The fate of the leucine taken up by the peripheral tissues is unclear. Net protein synthesis in skeletal muscle may be stimulated by leucine [2] . However, in the absence of increased availability of a full complement of essential amino acids, as after a protein meal, stimulation of protein synthesis was probably small. Alternatively, some of the leucine may have been transaminated and released to the circulation as 2-oxoisocaproate [22, 28] . The present data do not, however, give any clue as to what happened to the amino group. Except for a lower glutamate uptake during leucine infusion (series A), there was no change in the release of amino acids from the leg tissues. Specifically, alanine release did not increase during any of the three infusions. We have previously suggested that this could be due to a low availability of pyruvate in the resting muscle, thereby preventing an increase in the transamination t o alanine [21] . However, in view of the present observation of an unchanged alanine release also during the infusion of leucine plus glucose (series B), this explanation appears less probable. The uptake of leucine by the leg tissues was of the order of 80pmol/min in all three series. During 150 min of infusion these tissues thus disposed of about 12 mmol of amino groups. Assuming a muscle mass of 15 kg in the legs this corresponds to an increase in concentration of 0.8 mmol/kg. In view of the large pool of amino acids into which the extra amino groups could be distributed (e.g. glutamine 18 mmol/kg, glutamate 4 mmol/kg and alanine 2.5 mmol/kg) [29] , the changes in intramuscular amino acid concentrations during the different leucine infusions may have been small enough not to elicit an augmented release of amino acids to the circulation.
Insulin administration is known to reduce the plasma concentrations of most amino acids [30]. In agreement with this, hyperinsulinaemia in the present study (series B) was accompanied by a slightly more pronounced fall in arterial amino acid concentrations than was leucine infusion alone. In contrast, during hypoinsulinaemia (series C ) the blood levels of amino acids were less affected. These observations suggest that insulin and leucine exert an additive effect in the stimulation of amino acid disposal.
The splanchnic uptake of leucine averaged 60-70 pmol/min during the three different infusions. In series A and C this was accompanied by an augmented ketogenesis (about 1 15 and 270 pmol/ min respectively during the infusions). Considering that 1 mol of leucine can give rise to 1.5 mol of acetoacetate it may be assumed that the splanchnic uptake of leucine in series A was quantitatively converted into ketones by the liver. In series C an increased availability of FFA (Table 2 ) and the fall in insulin levels may have contributed to the accelerated ketogenesis. In contrast, after the rise in insulin concentration during leucine and glucose infusion (series B) the production of ketone bodies decreased and the fate of leucine during this infusion cannot be determined from the current data.
In the isolated rat diaphragm ketone bodies are known to interfere with branched chain amino acid metabolism [31] . In this regard it is noteworthy that leucine uptake by the leg was similar in series A, B and C, irrespective of the varying ketone body concentrations. Thus the present study does not indicate an influence of ketone bodies on leucine disposal in man at the levels (100-800 pmol/l) that were obtained under the present experimental conditions. This is in agreement with previous studies on leucine disposal during infusion of a fat emulsion, resulting in increased ketone levels [32] .
